This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | UMassMed |
| Website | http://www.umassmed.edu |
| Twitter username | UMassMedNow |
| Wikipedia page | https://en.wikipedia.org/wiki/University_of_Massachusetts_Medical_School |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 11 | 250,000 | 595,444 | 75,000 | 97,750 | 100,000 | 176,500 | 204,881 | 250,000 | 259,690 | 998,034 | 1,000,000 | 1,420,964 | 1,967,060 |
| Developmental Disabilities | 2 | 75,000 | 537,500 | 75,000 | 75,000 | 75,000 | 75,000 | 75,000 | 75,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
| Working Longer | 2 | 97,750 | 173,875 | 97,750 | 97,750 | 97,750 | 97,750 | 97,750 | 97,750 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 |
| Global health | 5 | 998,034 | 949,150 | 100,000 | 100,000 | 100,000 | 259,690 | 259,690 | 998,034 | 998,034 | 1,420,964 | 1,420,964 | 1,967,060 | 1,967,060 |
| 1 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | 176,500 | |
| FIXME | 1 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 | 204,881 |
| Donor | Total | 2018 | 2017 | 2014 | 2013 | 2012 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 4,745,748.00 | 1,680,654.00 | 1,967,060.00 | 0.00 | 1,098,034.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| John Merck Fund (filter this donee) | 1,075,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,000,000.00 | 75,000.00 | 0.00 | 0.00 |
| Sloan Foundation (filter this donee) | 347,750.00 | 0.00 | 0.00 | 97,750.00 | 0.00 | 250,000.00 | 0.00 | 0.00 | 0.00 |
| Wellcome Trust (filter this donee) | 204,881.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 204,881.00 |
| W. K. Kellogg Foundation (filter this donee) | 176,500.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 176,500.00 | 0.00 |
| Total | 6,549,879.00 | 1,680,654.00 | 1,967,060.00 | 97,750.00 | 1,098,034.00 | 1,250,000.00 | 75,000.00 | 176,500.00 | 204,881.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 11) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 1,420,964.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advance oral immunooprophylaxis against enteric pathogens. Oral Immunoprotection by Secretory IgA Against Enterotoxigenic Escherichia Coli (ETEC) Infection. Investment start date: 5/4/2017 to end date: 11/30/2019. Grantee name: University of Massachuse; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 259,690.00 | 5 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advance oral immunooprophylaxis against enteric pathogens. Oral Immunoprotection by Secretory IgA Against Enterotoxigenic Escherichia Coli (ETEC) Infection. Investment start date: 5/4/2017 to end date: 11/30/2019. Grantee name: University of Massachuse; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,967,060.00 | 1 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advance oral immunooprophylaxis against enteric pathogens. Oral Immunoprotection by Secretory IgA Against Enterotoxigenic Escherichia Coli (ETEC) Infection. Investment start date: 5/4/2017 to end date: 11/30/2019. Grantee name: University of Massachuse; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Sloan Foundation | 97,750.00 | 10 | Working Longer/ | https://sloan.org/grant-detail/7003 | -- | Grant investigator: Luanne Thorndyke; to conduct a national conference to identify and disseminate generalizable principles, strategies, interventions, and tools that can be used to advance faculty career flexibility in medical schools throughout the career lifecycle from recruitment through retirement. | |
| Bill and Melinda Gates Foundation | 998,034.00 | 4 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop RNA silencing as a novel therapeutic approach for treatment of preeclampsia in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To enhance treatment efficacy for parasitic roundworm infections by identifying molecular features that can easily penetrate these nematodes and testing them using a novel drug predicted to inhibit the nematode’s nervous system.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| John Merck Fund | 1,000,000.00 | 3 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: Translational Research ProgramTo support research into Down Syndrome by Jeanne Lawrence. Four year grant 2013-2017. | |
| Sloan Foundation | 250,000.00 | 6 | Working Longer/ | https://sloan.org/grant-detail/7044 | -- | Grant investigator: Luanne Thorndyke; to further accelerate the school's progress in achieving faculty career flexibility. Funds granted to institution as a winner of the 2012 Alfred P. Sloan Award for Faculty Career Flexibility in Medical Schools. | |
| John Merck Fund | 75,000.00 | 11 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research on visual processing in children with dyslexia and their siblings by John Merck Scholar Ann Skoczenski. | |
| W. K. Kellogg Foundation | 176,500.00 | 8 | -- | https://www.wkkf.org:443/grants/grant/2003/07/improve-oral-health-in-central-massach-p0101110 | -- | Purpose: Improve oral health services in several communities by implementing and expanding interventions; Grant period: 2003-07-01 to 2009-09-30. Affected countries: United States; affected states: Massachusetts. | |
| Wellcome Trust | 204,881.00 | 7 | FIXME | https://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx | -- | MyD88-adapter-like (Mal), a target for specific intervention in infectious disease. Affected regions: International; affected countries: United States. |